BiotechTube
Home/Poolbeg Pharma/Jeremy Skillington
JS

Jeremy Skillington

Chief Executive Officer

Poolbeg Pharma

Therapeutic Areas

Oncology Supportive CareMetabolic Disease (Obesity)Infectious Disease

Poolbeg Pharma Pipeline

DrugIndicationPhase
POLB 001Prevention of Cancer Immunotherapy-Induced Cytokine Release Syndrome (CRS)Phase 1b/2
Oral Encapsulated GLP-1ObesityPreclinical
AI Programme - InfluenzaInfluenzaDiscovery
AI Programme - RSVRespiratory Syncytial Virus (RSV)Discovery

Leadership Team at Poolbeg Pharma

CF
Cathal Friel
Executive Chair
IO
Ian O'Connell
Chief Financial Officer
View full Poolbeg Pharma profile